- Visibility 465 Views
- Downloads 382 Downloads
- Permissions
- DOI 10.18231/j.ijmpo.2025.008
-
CrossMark
Comparison of Intensity-modulated radiation therapy (IMRT) versus RapidArc technique in head and neck cancers – A dosimetric and clinical research
- Author Details:
-
Dimbeswar Roy
-
Preety Negi *
-
Himanshu Srivastava
-
Harnoor Singh Pruthi
-
Raja Sellapandiyan
Dimbeswar Roy
Preety Negi *
Himanshu Srivastava
Harnoor Singh Pruthi
Raja Sellapandiyan
Introduction: Head and neck cancers (HNC) result in significant morbidity and mortality throughout the world, with an expected 900,000 cases and 400,000 deaths annually. In India, head and neck cancer accounts for 30% of all cancer cases, with >65% of patients presenting with locally advanced disease.
Objectives: To compare the dosimetric (target volume coverage, dose to organs at risk (OARs), and monitor units (MUs) and clinical (mucositis and dermatitis) parameters in patients receiving IMRT versus RapidArc in HNC.
Materials and Methods: This cross-sectional, prospective study of locally advanced head and neck cancer patients (oral cavity, oropharynx, larynx, hypopharynx) was conducted on those planned for treatment with definitive concurrent chemoradiation therapy from 01.06.2023 to 31.05.2024 at Capitol Hospital, Jalandhar. These patients were randomly allocated to the IMRT or RapidArc group. The patients with previous irradiation for HNC, metastatic disease, and those who underwent surgery were excluded from the study. The target volume coverage, OARs doses, and MUs with weekly radiation-induced mucositis and dermatitis were assessed in the IMRT and RapidArc arm.
Results: A total of 26 patients were randomized into the IMRT and RapidArc group. There was no statistically significant difference between IMRT and RapidArc techniques in terms of target dose coverage for PTV70 and PTV59.4 Gy. The dose to OARs including mandible, lips, unilateral parotid, bilateral parotid, and spinal cord was similar for both IMRT and RapidArc techniques. The average MU to deliver a dose of 2Gy per fraction in the RapidArc technique was fewer as compared to those with the IMRT technique (p<0>
Conclusion: Our study concluded that the only significant benefit with RapidArc was much smaller total MUs required than with IMRT. Both techniques were comparable concerning target coverage and dose to OARs. However, we noticed that IMRT resulted in higher grade 3 mucositis though not statistically significant.
Keywords: Dermatitis, Head and neck neoplasms, Intensity-modulated radiotherapy, Mucositis, Organs at risk
References
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of Roy et al / IP International Journal of Medical Paediatrics and Oncology 2025;11(2):34-39 39 incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
- Anderson G, Ebadi M, Vo K, Novak J, Govindarajan A, Amini A. An Updated Review on Head and Neck Cancer Treatment with Radiation Therapy. Cancers 2021;13(19):4912.
- Ali MA, Babaiah M, Madhusudan N, George G, Jain S, Ramalingam K, et al. Comparative dosimetric analysis of IMRT and VMAT in brain, head and neck, breast, and prostate malignancies. Int J Cancer Ther Oncol. 2015;3(1):03019.
- Infusino E. Clinical utility of RapidArc radiotherapy technology. Cancer Manag Res. 2015;7:345–56.
- Mashhour K, Kamaleldin M, Hashem W. RapidArc versus Conventional IMRT for Head and Neck Cancer Irradiation: Is Faster Necessary Better? Asian Pac J Cancer Prev. 2018;19(1):207–11.
- Jaiswal I, Prakash C, Khurana R, Singal U. Original Research Article Evaluation of efficacy & toxicity in Head and neck cancer patients treated with Volumetric Intensity Modulated Arc Therapy (VMAT) vs conventional Intensity Modulated Radiation Therapy (IMRT). Eur J Molec Clinical Med. 2022;9.
- Chauhan R, Trivedi V, Rani R, Singh U. A Study of Head and Neck Cancer Patients with reference to Tobacco Use, Gender, and Subsite Distribution. South Asian J Cancer. 2022;11(1):46–51.
- Studenski MT, Bar-Ad V, Siglin J, Cognetti D, Curry J, Tuluc M, et al. Clinical experience transitioning from IMRT to VMAT for head and neck cancer. Med Dosim. 2013;38(2):171–5.
- Fung-Kee-Fung SD, Hackett R, Hales L, Warren G, Singh AK. A prospective trial of volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in advanced head and neck cancer. World J Clin Oncol. 2012;3(4):57–62.
- Leung WS, Wu VWC, Liu CYW, Cheng ACK. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity-modulated radiotherapy. J Appl Clin Med Phys. 2019;20(11):121–30.
- Broggi S, Perna L, Bonsignore F, Rinaldin G, Fiorino C, Chiara A, et al. Static and rotational intensity-modulated techniques for head- neck cancer radiotherapy: a planning comparison. Phys Med. 2014;30(8):973–9.
- Osborn J. Is VMAT beneficial for patients undergoing radiotherapy to the head and neck? Radiography (Lond). 2017;23(1):73–6.
- Iovoli AJ, Turecki L, Qiu ML, Michael K, Kelsey S, Yu YH, et al. Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer. JAMA Netw Open. 2023;6:e2337265.
- Blakaj A, Bonomi M, Gamez ME, Blakaj DM. Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data. Oral Oncol. 2019;95:29–34.
- Judge LF, Farrugia MK, Singh AK. Narrative review of the management of oral mucositis during chemoradiation for head and neck cancer. Ann Transl Med. 2021;9(10):916.
- Liu M, An R, Wu Z, Dai L, Zeng Q, Chen W. The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and its Influencing Factors. Ear Nose Throat J. 2025;104(5):NP257–69.